Results 131 to 140 of about 141,466 (220)
GLP‐1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications
Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists provide benefits in weight reduction, glycaemic control in Type 2 diabetes, and cardiovascular and renal outcomes. Their widespread use has given rise to concerns regarding rare but potentially serious adverse events.
Peter Ueda
wiley +1 more source
ABSTRACT In a recent publication, Lapitz et al. reported differences in serum levels that predict the development of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis prior to clinical manifestation. We examined whether these biomarkers also predict the risk of gallbladder cancer (GBC) in European prospective plasma samples from ...
Linda Zollner +4 more
wiley +1 more source
Shikonin: From Biosynthesis and Pharmacological Mechanisms to Translational Safety and Drug Delivery
Shikonin, biosynthesised in Boraginaceae roots from phenylalanine‐derived PHB and isoprenoid GPP, modulates redox balance, cellular stress, signalling pathways, and regulated cell death. Preclinical studies support diverse pharmacological activities, while nanocarriers improve dispersion and delivery.
Namini Joshi +6 more
wiley +1 more source
Benign Neoplasms of the Gallbladder*
S F, OCHSNER, A, OCHSNER
openaire +3 more sources
Intracholecystic Papillary-Tubular Neoplasm of the Gallbladder [PDF]
Saba, Yasir, Lori A, Erickson
openaire +2 more sources
Liver organoids: modelling complexity in homeostasis and disease
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley +1 more source
Intracholecystic papillary neoplasm (ICPN) of gallbladder. a case report [PDF]
In the WHO Classification of Tumours of the Digestive System (2019), intracholecystic papillary neoplasm (ICPN), a pre-invasive neoplasm of the gallbladder, is described as non-invasive epithelial neoplasm with macroscopically discernible mass of pure ...
Mohtarrudin, Norhafizah +2 more
core +2 more sources
Background: Intracholecystic papillary neoplasms (ICPNs) represent a rare benign entity characterized by intraluminal polypoid lesions in the gallbladder. The incidence of ICPNs ranges from 0.4% to 0.61% in all gallbladder specimens.
Gafà, Roberta +6 more
core +1 more source
Abstract Aim Liquid biopsy is minimally invasive (compared with tissue biopsy) and has previously been used to generate systems data regarding drug elimination via hepatic enzymes and transporters. This study extends quantitative assessment of systems parameters in liquid biopsy to pharmacodynamic (PD) and disease markers relevant to cancer development
Zubida M. Al‐Majdoub +3 more
wiley +1 more source
Study design and main findings. After 1:1 propensity score matching, 60 885 PCSK9 inhibitor users and 60 885 statin‐only users with ASCVD were compared. Kaplan–Meier curves show 12‐month cumulative event‐free survival for MACE, psychiatric disease, and neurodegenerative disease.
Tianshu Gu +7 more
wiley +1 more source

